Yulin Ren | Health Professions | Excellence in Innovation Award

Published on by Global Scholar Awards

Dr. Yulin Ren | Health Professions | Excellence in Innovation Award

Sr. Research Scientist | The Ohio State University | United States

Dr. Yulin Ren is a leading researcher at The Ohio State University, Columbus, United States, with expertise in medicinal chemistry, natural product research, pharmacology, and anticancer drug discovery. His research focuses on isolating and characterizing bioactive natural compounds and evaluating their therapeutic potential against cancer and cardiovascular diseases. Dr. Ren has contributed a substantial body of peer-reviewed publications that have gained international recognition for their scientific rigor and translational relevance. His work spans studies on cardiac glycosides, alkaloids, and plant-derived bioactive molecules, highlighting innovative strategies for developing next-generation therapeutics. Collaborating extensively with a wide network of interdisciplinary and international researchers, he integrates chemistry, biology, and pharmacology to advance drug discovery and translational research. Dr. Ren’s contributions have meaningful societal impact by offering new avenues for effective cancer and cardiovascular treatments, promoting public health, and fostering innovation in medicinal chemistry. His research exemplifies a bridge between laboratory discoveries and clinical applications.

Citation Metrics (Scopus)

1925
1500
1000
500
0

Citations

1,925

Documents

67

h-index

25

Citations

Documents

h-index

View Google Scholar Profile View Scopus Profile

Featured Publications


Development of anticancer agents from plant-derived sesquiterpene lactones

– Current Medicinal Chemistry, 2016 (Citations: 186)

Guillermo Docena | Health Professions | Research Excellence Award

Published on by Global Scholar Awards

Dr. Guillermo Docena | Health Professions | Research Excellence Award

Investigador Principal | Universidad Nacional de La Plata | Argentina

Dr. Guillermo Horacio Docena is a distinguished immunologist at the Instituto de Estudios Inmunológicos y Fisiopatológicos, CONICET–Universidad Nacional de La Plata, Argentina. His research expertise lies in immunopathology, mucosal and cellular immunology, inflammatory processes, host–pathogen interactions, and vaccine-related immune responses. His scholarly work spans both fundamental and translational research, addressing topics such as neuroinflammation, extracellular vesicles, immune modulation using nanocarriers, food allergy, pediatric immune disorders, and immunogenicity of vaccination strategies. Dr. Docena is widely recognized for his sustained scientific contributions and strong international visibility, reflected in extensive peer-reviewed publications and high citation impact. He actively collaborates with researchers across disciplines and countries, strengthening global research networks in immunology and biomedical sciences. His research has contributed to improved understanding of immune mechanisms and has supported the development of innovative therapeutic and preventive approaches, demonstrating meaningful societal and public health relevance worldwide.

Citation Metrics (Scopus)

1901
1500
1000
500
0

Citations

1,901

Documents

69

h-index

26

Citations

Documents

h-index

View Google Scholar Profile
 View Scopus Profile
 View ORCID Profile

Featured Publications

Ming-Yow Hung | Medicine and Dentistry | Research Excellence Award

Published on by Global Scholar Awards

Prof. Ming-Yow Hung | Medicine and Dentistry | Research Excellence Award

Professor | Shuang Ho Hospital, Taipei Medical University | Taiwan

Dr. Ming Yow Hung is a distinguished researcher at Taipei Medical University, Taiwan, specializing in cardiovascular biology, molecular cardiology, and stem cell research. His work focuses on understanding coronary artery disorders, including vasospasm, Kounis syndrome, and allergic myocardial infarction, through experimental, translational, and epigenetic approaches. He has authored numerous peer-reviewed publications, with significant citation impact reflecting his influence in cardiovascular and pharmaceutical research. Dr. Hung collaborates extensively with international teams, contributing to multidisciplinary studies that integrate molecular mechanisms, induced pluripotent stem cell models, and clinical insights. His research advances understanding of disease mechanisms and informs therapeutic strategies, with clear societal relevance in improving cardiovascular health, personalized medicine, and patient care, positioning him as a globally recognized and impactful scientist in cardiovascular research.

Citation Metrics (Scopus)

1,824
1,400
900
450
0

Citations

1,824

Documents

57

h-index

20

Citations

Documents

h-index

View Scopus Profile
 View ORCID Profile

Featured Publications

Shaoqing Yu | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Prof. Dr. Shaoqing Yu | Medicine and Dentistry | Best Researcher Award

Directors of Department in Hospital| Tongji University | China

Dr. Shaoqing Yu, PhD, is the Director of the Departments of Otorhinolaryngology–Head and Neck Surgery and Allergy at Tongji Hospital, School of Medicine, Tongji University, Shanghai, China. An accomplished clinician-scientist, Dr. Yu specializes in allergy, immunology, and otorhinolaryngology, with a research focus on the mechanisms and clinical management of allergic rhinitis and upper airway inflammation. He has led or participated in more than 20 major research projects, including those funded by the National Natural Science Foundation of China, and has published over 70 peer-reviewed papers in high-impact international journals such as JAMA, Allergy, Clinical and Experimental Allergy, and Clinical Reviews in Allergy & Immunology. His work has substantially advanced understanding of immune regulation and translational therapies in allergic diseases. Dr. Yu is an active member of the European Academy of Allergy and Clinical Immunology (EAACI) and the Chinese Society of Otolaryngology in Traditional Chinese and Western Medicine, fostering global and interdisciplinary collaborations. His achievements have been recognized through numerous awards, including the Third Prize of the Shanghai Medical Technology Award, the Third Prize of the Military Medical Achievement Award, and the Tongji University Taihe Medical Education Award. With over 20 patents to his name and selection for the prestigious Shanghai Oriental Talent Plan, Dr. Yu continues to contribute significantly to medical innovation, education, and the improvement of public health outcomes in China and internationally.

Profiles: Scopus | ORCID 

Featured Publications

Yu, S., et al. (2025). An anti-TSLP monoclonal antibody for uncontrolled CRSwNP: The DUBHE randomized clinical trial. Nature Communications.

Yu, S., et al. (2025). Efficacy and safety of intranasal corticosteroids combined with mucoactive drugs for chronic rhinosinusitis. International Immunopharmacology.

Yu, S., et al. (2025). Xylulose 5-phosphate fosters sustained antitumor activity of progenitor-like exhausted SLC35E2⁺ CD8⁺ T effector cells. Cell Metabolism.

Yu, S., et al. (2025). Automatic segmentation of clear cell renal cell carcinoma based on deep learning and a preliminary exploration of the tumor microenvironment. Translational Andrology and Urology.

Yu, S., et al. (2025). Long-term administration of hydrogen-rich water enhances quality of life in diabetic rats and reduces renal neoplasm incidence through modulation of inflammatory and metabolic pathways. Translational Andrology and Urology.

Dr. Shaoqing Yu’s pioneering research in allergy and immunology has advanced understanding of airway inflammatory diseases and driven the development of innovative diagnostic and therapeutic strategies. His work bridges basic science and clinical application, improving patient outcomes and shaping global standards in allergic disease management.

Aylin Köseler | Medicine | Best Researcher Award

Published on by Global Scholar Awards

Prof. Dr. Aylin Köseler | Medicine | Best Researcher Award

Professor | Pamukkale University Medical Faculty | Turkey

Professor Aylin Köseler is a distinguished academic in the field of biophysics and molecular genetics, currently serving in the Department of Biophysics at Pamukkale University Faculty of Medicine. Her extensive research career spans over two decades, focusing on the molecular mechanisms underlying genetic variability, pharmacogenomics, and disease susceptibility. She has made significant contributions to understanding gene–environment interactions, genetic polymorphisms, and epigenetic regulations associated with cardiovascular diseases, metabolic disorders, and infectious diseases such as COVID-19. Prof. Köseler has led and participated in numerous national and international research projects, including collaborations with prestigious institutions such as Harvard Medical School and the University of California, Los Angeles (UCLA). Her notable involvement in projects like Whole Genome Sequencing of Ancient DNA and Epigenetics in Identical Twins and COVID-19 Patients demonstrates her commitment to interdisciplinary science bridging genetics, biophysics, and clinical medicine. Throughout her academic tenure, she has supervised graduate research and contributed to advancing biomedical science through experimental and computational biophysics approaches. She has authored and co-authored numerous peer-reviewed publications and presented her work at scientific conferences worldwide. Her research outputs have been recognized for their scientific rigor and impact on personalized medicine, population genetics, and evolutionary biology. Beyond academic excellence, Prof. Köseler’s work has substantial societal implications, particularly in improving diagnostic precision, therapeutic efficacy, and public health outcomes. Her dedication to fostering young researchers and promoting collaborative innovation underscores her leadership in the Turkish and international scientific communities. Her ongoing projects continue to explore genetic determinants of complex diseases and epigenetic modulation, contributing valuable insights to the global biomedical research landscape.

Profiles: Google Scholar | Scopus | ORCID | ResearchGate | LinkedIn

Featured Publications

  1. Sabirli, R., Köseler, A., Goren, T., Turkcuer, I., & Kurt, O. (2021). High GRP78 levels in COVID-19 infection: A case-control study. Life Sciences, 265, 118781. https://doi.org/10.1016/j.lfs.2020.118781 — Cited by: 128

  2. Palmeira, A., Sousa, E., Köseler, A., Sabirli, R., Gören, T., Türkçüer, İ., Kurt, Ö., et al. (2020). Preliminary virtual screening studies to identify GRP78 inhibitors which may interfere with SARS-CoV-2 infection. Pharmaceuticals, 13(6), 132. https://doi.org/10.3390/ph13060132 — Cited by: 77

  3. Köseler, A., Sabirli, R., Gören, T., Türkçüer, İ., & Kurt, Ö. (2020). Endoplasmic reticulum stress markers in SARS-CoV-2 infection and pneumonia: Case-control study. In Vivo, 34(3 Suppl), 1645–1650. https://doi.org/10.21873/invivo.11938 — Cited by: 75

  4. Akca, H., Demiray, A., Yaren, A., Bir, F., Koseler, A., Iwakawa, R., Bagci, G., et al. (2013). Utility of serum DNA and pyrosequencing for the detection of EGFR mutations in non-small cell lung cancer. Cancer Genetics, 206(3), 73–80. https://doi.org/10.1016/j.cancergen.2013.05.012 — Cited by: 58

  5. Atalay, E. Ö., Koyuncu, H., Turgut, B., Atalay, A., Yildiz, S., Bahadir, A., & Köseler, A. (2005). High incidence of Hb D-Los Angeles [β121 (GH4) Glu→ Gln] in Denizli Province, Aegean region of Turkey. Hemoglobin, 29(4), 307–310. https://doi.org/10.1080/03630260500217438 — Cited by: 50

Sergey Suchkov | Clinical Immunology | Excellence in Innovation Award

Published on by Global Scholar Awards

Prof. Sergey Suchkov | Clinical Immunology | Excellence in Innovation Award

Professor in Medicine and Immunology | N.D. Zelinskii Institute for Organic Chemistry | Russia

Prof. Sergey V. Suchkov, MD, PhD, is a distinguished physician-scientist and international leader in immunology, personalized and precision medicine, and biodesign. Born in Astrakhan, Russia, he graduated with an MD from Astrakhan State Medical University in 1980 and earned his PhD from Sechenov University in 1985, followed by a Doctor’s Degree from the National Institute of Immunology in 2002. His professional experience spans over four decades, including senior research positions at the USSR Academy of Medical Sciences, the Moscow Clinical Research Institute (MONIKI), and leadership roles as Director of the Center for Personalized & Precision Medicine at Sechenov University, Vice-Director of the Institute for Biotech & Global Health at RosBioTech National University, and Director of the Center for Biodesign at N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences. He has contributed to international collaborations, with advanced training and research engagements at the NEI, NIH, USA, Wills Eye Hospital, Philadelphia, and invited work at several British universities under the Royal Society for Immunology. Prof. Suchkov’s research interests include clinical immunology, predictive and preventive medicine, precision nutrition, and translational biodesign, underpinned by skills in immunobiotechnology, personalized therapy design, clinical trial management, and biomedical innovation. He has authored numerous publications in reputed journals and conferences (IEEE, Scopus-indexed) and actively participates in global professional societies including EPMA, ISPM, PMC, ACS, AHA, ARVO, ISER, and AMEE. Recognized for his leadership and contributions to medical education and clinical practice, he has received multiple honors and holds key advisory roles in international research organizations. Prof. Suchkov’s exceptional expertise, global collaborations, and mentorship capacity position him to advance personalized medicine and immunology research worldwide, foster innovation, and continue contributing to healthcare and scientific communities at the highest level, making him a highly deserving candidate for recognition and awards in his field. 989 Citations | 87 Documents | 12 h-index.

Profiles: Scopus | ORCID | ResearchGate | LinkedIn

Featured Publications

  1. Suchkov, S. V., Revishvili, A. S., Charchyan, E. R., & Belov, Y. V. (2025). Towards highly precise treatment and rehabilitation in practice of modern cardiologist, cardiac surgeon and cardiac rehabilitation professional.

  2. Suchkov, S. V., Charchyan, E. R., Polyakova, V. N., & Belov, Y. V. (2025). On the path to personalized cardiology: prospects of precise assessment of cardiovascular risks and predictive-prognostic diagnostics.

  3. Suchkov, S. V., Abe, H., Murphy, S., & Suvorov, A. N. (2024). Human Health, Environmental Comfort and Well-Being. Part 2. Ecological Comfort as a New and Strategic Factor in the Protection of Modern Human Health.

  4. Suchkov, S. V., Abe, H., Murphy, S., & Suvorov, A. N. (2024). Human Health, Environmental Comfort and Well-Being. Part 1. Engineering and Design Resources of the Bioindustry on the Way to Safe Competition with the Resources of Natural Biocenoses and Health-Saving Systems.

  5. Suchkov, S. V., Abe, H., Murphy, S., & Suvorov, A. N. (2024). Health, Environmental Comfort and Wellbeing through the Integration of Natural and Engineering-Design Bioresources: At the Junction of Pharmaco- and Nutriodesign to the Bioindustry of Tomorrow.

Elena Popa | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Assoc. Prof. Dr. Elena Popa | Medicine and Dentistry | Best Researcher Award

Lecturer at “Grigore T. Popa” University of Medicine and Pharmacy Iasi, Romania

Dr. Elena Popa is a distinguished Senior Lecturer at “Grigore T. Popa” University of Medicine and Pharmacy in Iași, Romania, with over 20 years of academic experience in Family and Preventive Medicine. Her research career, grounded in a Ph.D. on PPAR receptors and metabolic syndrome, has evolved to address critical public health issues such as chronic inflammation, Long COVID, and PCOS. She has published extensively in peer-reviewed journals and book chapters, actively contributing to national screening programs and interdisciplinary health initiatives. Dr. Popa uniquely integrates clinical practice with academic research, promoting evidence-based approaches in primary care. Her dedication to preventive strategies and translational research makes her a strong candidate for the Best Researcher Award. While further international collaboration and visibility of research metrics would enhance her profile, her impactful contributions to education, clinical practice, and public health firmly establish her as a leading figure in her field.

Professional Profile 

Education🎓

Dr. Elena Popa has a strong educational background in medical sciences, culminating in a Ph.D. in Medical Sciences obtained in 2014. Her doctoral research focused on “The Role of PPAR Receptors in Metabolic Syndrome,” demonstrating her early and sustained interest in the complex mechanisms underlying metabolic and inflammatory disorders. She pursued her medical education at the “Grigore T. Popa” University of Medicine and Pharmacy in Iași, Romania, where she currently serves as a Senior Lecturer. Over the years, Dr. Popa has continued to expand her knowledge through active participation in academic and professional development programs, including national and international conferences, workshops, and continuing medical education (CME) courses. Her academic journey reflects a commitment to both clinical excellence and research innovation, with a special focus on family medicine, preventive healthcare, and chronic disease pathophysiology. This solid educational foundation supports her role as both a researcher and a mentor in the medical field.

Professional Experience📝

Dr. Elena Popa has over two decades of professional experience in the fields of medical education, clinical practice, and research. She currently holds the position of Senior Lecturer in the Department of Preventive Medicine and Interdisciplinarity at the “Grigore T. Popa” University of Medicine and Pharmacy in Iași, Romania. In this role, she is deeply involved in teaching and mentoring medical students and residents, particularly in Family Medicine and Preventive Medicine. Alongside her academic duties, Dr. Popa maintains an active clinical practice as a family physician, enabling her to apply research insights directly to patient care. Her professional contributions also include involvement in national health screening programs, public health campaigns, and interdisciplinary healthcare initiatives. She frequently lectures at national conferences and continuing medical education programs, reinforcing her commitment to advancing healthcare knowledge and practice. Dr. Popa’s combined academic, clinical, and research roles exemplify her dedication to improving healthcare outcomes through integrated, evidence-based approaches.

Research Interest🔎

Dr. Elena Popa’s research interests center on the intersection of chronic inflammation, metabolic disorders, and public health. Her early work, initiated during her Ph.D. studies on the role of PPAR receptors in metabolic syndrome, laid the foundation for a broader exploration into inflammatory mechanisms underlying complex syndromes. She is particularly focused on conditions such as Long COVID and Polycystic Ovary Syndrome (PCOS), examining their links to endocrine dysfunction and systemic inflammation. Dr. Popa is also deeply engaged in preventive medicine, with an emphasis on improving primary care strategies and promoting early detection and intervention for chronic diseases. Her research bridges basic science and clinical application, aiming to translate findings into practical healthcare solutions. Through interdisciplinary collaboration and participation in national health programs, she seeks to enhance public health outcomes. Her work is characterized by a commitment to integrating medical research with education and community-based clinical practice.

Award and Honor🏆

Dr. Elena Popa has earned recognition and respect throughout her career for her outstanding contributions to medical education, clinical practice, and research. Her dedication to advancing preventive medicine and chronic disease management has been acknowledged through invitations to speak at numerous national conferences and continuing medical education (CME) programs. She has been honored for her active involvement in national health screening initiatives and interdisciplinary public health projects, which have had a meaningful impact on community health outcomes. As a mentor and educator, Dr. Popa has received commendations from academic institutions and professional organizations for her commitment to student training and resident development in family medicine. While specific awards are not explicitly listed, her sustained professional excellence, research productivity, and leadership in both academic and clinical settings reflect a career marked by distinction. Her reputation as a respected physician-researcher underscores her suitability for high-level academic and scientific honors, including the Best Researcher Award.

Research Skill🔬

Dr. Elena Popa possesses a comprehensive set of research skills that span both theoretical analysis and practical application in clinical and public health settings. Her expertise includes designing and conducting clinical and epidemiological studies, with a strong foundation in evidence-based medicine. She is adept at scientific writing, having authored and co-authored numerous peer-reviewed journal articles and book chapters focused on chronic inflammation, metabolic disorders, and preventive healthcare. Dr. Popa demonstrates skill in data interpretation, literature synthesis, and the integration of interdisciplinary perspectives, particularly in exploring the complex interactions between inflammation, endocrine dysfunction, and chronic disease. Her ability to translate research findings into real-world clinical strategies highlights her strength in translational research. Additionally, she effectively collaborates across academic and healthcare sectors, contributing to national screening programs and health initiatives. Her dual roles as a practicing physician and academic researcher enable her to apply rigorous scientific inquiry directly to patient care and healthcare improvement.

Conclusion💡

Dr. Elena Popa is a highly qualified and impactful candidate for the Best Researcher Award, especially for domains focused on preventive medicine, chronic disease pathophysiology, and translational clinical research. Her blend of long-term academic involvement, interdisciplinary focus, and commitment to applying research in clinical settings is commendable.

Publications Top Noted✍️

  • The Significance of Low Magnesium Levels in COVID-19 Patients

    • Authors: EA Coman, A Ceasovschih, AD Petroaie, E Popa, C Lionte, C Bologa, …

    • Year: 2023

    • Citations: 21

  • Stress: from symptom to disease

    • Authors: MG Traian, AE Coman, L Traian, R Petrovanu

    • Year: 2013

    • Citations: 8

  • Epidemiological study of metabolic syndrome and risk of diabetes mellitus in a rural family medicine practice in Bacau County

    • Authors: D Alamir, P Elena, A Bacusca, MG Traian, R Petrovanu, AE Coman

    • Year: 2014

    • Citations: 5

  • Flow Cytometry Analysis of Pparα Receptors in Metabolic Syndrome

    • Authors: E Popa, F Zugun-Eloae, M Zlei, D Jitaru, OM Pintilie, AE Coman, M Traian, …

    • Year: 2014

    • Citations: 4

  • Non-invasive Serological Markers of Hepatic Fibrosis – Mini Review

    • Authors: E Popa, RI Avram, AE Popa, AE Coman

    • Year: 2024

    • Citations: 3

  • PEX6 Mutation in a Child with Infantile Refsum Disease—A Case Report and Literature Review

    • Authors: AM Slanina, EA Coman, D Anton-Paduraru, E Popa, CL Barbacariu, …

    • Year: 2023

    • Citations: 3

  • Pelvic inflammatory disease

    • Authors: E Popa, AA Chis-Srban, C Manole, A Coman

    • Year: 2019

    • Citations: 3*

  • O analiza SWOT a rezultatelor screeningului de cancer de col uterin (2012–2016)

    • Authors: G Calfa, E Popa, D Pletea, M Grigore, I Pavaleanu

    • Year: 2016

    • Citations: 3

  • The “Viral” Form of Polyarteritis Nodosa (PAN)—A Distinct Entity: A Case Based Review

    • Authors: V Pasa, E Popa, M Poroch, A Cosmescu, AI Bacusca, AM Slanina, …

    • Year: 2023

    • Citations: 2

  • The Effects of the COVID-19 Pandemic on Mental Health: A Web-Based Study Among Romanian Adults

    • Authors: E Popa, T Tetia, M Poroch, AE Coman

    • Year: 2022

    • Citations: 2

  • Methods of internet addiction screening for teens and young adults in Primary Care

    • Authors: AM Slanina, AD Petroaie, C Nasaudean, AI Bacusca, U Monica, …

    • Year: 2021

    • Citations: 2

  • Disfuncția endotelială – de la mecanisme moleculare la cuantificare și tratament în practica medicală

    • Authors: E Popa, MG Traian, A Bacusca, A Diaa, R Petrovanu, AE Coman

    • Year: 2014

    • Citations: 2

Arezina Kasti | Nutrition | Women Researcher Award

Published on by Global Scholar Awards

Dr. Arezina Kasti | Nutrition | Women Researcher Award

University General Hospital Attikon, Greece

Arezina Kasti is a highly experienced Registered Dietitian with three decades of clinical service and a strong focus on gastrointestinal nutrition. Currently a PhD candidate at the National and Kapodistrian University of Athens, her research investigates the effectiveness of a Mediterranean-adapted Low FODMAP Diet in managing Irritable Bowel Syndrome, with findings already published in reputable journals such as Nutrients and Microorganisms. She serves as a Senior Dietitian at a major public hospital in Greece and actively mentors dietetics students from multiple universities. Her academic involvement, specialized certifications, and consistent participation in national and international conferences reflect her dedication to both clinical excellence and scientific advancement. Her work bridges practical nutrition care and evidence-based research, making a meaningful impact in patient outcomes and dietary education. With her commitment to advancing gastrointestinal nutrition and mentoring the next generation, Arezina is a strong and deserving candidate for the Women Researcher Award.

Professional Profile 

Education🎓

Arezina Kasti holds a Bachelor’s degree in Nutrition and Dietetics from Harokopio University of Athens, completed in 1992, with clinical training at Tzaneio and Asklipieio General Hospitals. She pursued advanced studies in healthcare administration, earning a postgraduate diploma in Management in Health Services from the Hellenic Open University in 2003 and a second postgraduate diploma in Health Services Administration from the National School of Public Health in 2012. Currently, she is a PhD candidate at the Medical School of the National and Kapodistrian University of Athens, focusing her doctoral research on the effectiveness of a Mediterranean-adapted Low FODMAP Diet for managing irritable bowel syndrome symptoms. Additionally, she has completed specialized training courses, including the internationally recognized Low FODMAP Diet course by Monash University and various programs in health services and mental health administration in both Greece and Italy. Her education reflects a comprehensive blend of clinical nutrition, public health, and academic research excellence.

Professional Experience📝

Arezina Kasti has amassed over 30 years of professional experience as a clinical dietitian, beginning her career in 1992 at Medijeunesse, a center for medical aesthetics. She then joined the National Health Service at the Mental Hospital of Leros, where she worked in the Department of Clinical Nutrition and Dietetics from 1993 to 2004. Since 2004, she has served at the Attikon University Hospital in Athens, one of Greece’s largest tertiary public hospitals, and was promoted to Senior Dietitian in 2008. Her clinical focus centers on gastrointestinal diseases, nutritional therapy, and chronic disease management. In addition to her hospital work, she collaborates with educational institutions such as Harokopio University, Hellenic Mediterranean University, University of Thessaly, and Aegean College, supervising and mentoring dietetic students during their practical training. Her extensive experience, both in clinical care and academic mentorship, demonstrates a strong commitment to advancing dietetics practice and improving patient outcomes.

Research Interest🔎

Arezina Kasti’s research interests lie primarily in clinical nutrition, with a strong focus on gastrointestinal disorders, particularly Irritable Bowel Syndrome (IBS). Her PhD research investigates the integration of the Low FODMAP Diet with the Mediterranean diet—an innovative approach aimed at improving symptom management in IBS patients while maintaining nutritional adequacy. She is deeply interested in evidence-based dietary interventions for digestive health and has explored diverse topics such as nutritional strategies for chronic illnesses, nutritional support in intensive care units, and the impact of dietary adherence on metabolic and cardiovascular outcomes. Her work often bridges clinical practice and research, contributing to peer-reviewed publications and presenting findings at international conferences. Arezina is also engaged in the development and validation of clinical tools for assessing dietary impact in gastrointestinal disorders. Her commitment to translational research underscores her goal of enhancing patient care through tailored dietary protocols and advancing nutritional therapy in gastrointestinal healthcare.

Award and Honor🏆

Arezina Kasti has earned recognition through her extensive contributions to clinical nutrition and dietetics over the past three decades. While she has not listed formal awards, her accomplishments reflect a high level of professional esteem and influence in her field. She has been invited to present her research at prestigious international conferences such as the United European Gastroenterology (UEG) Week and the Middle East Congress on Clinical Nutrition, showcasing her innovative work on gastrointestinal nutrition and chronic disease management. Her recent publications in respected, peer-reviewed journals—including Nutrients and Microorganisms—underscore her growing impact on academic research. Additionally, her role as a senior clinical dietitian at one of Greece’s top tertiary hospitals and her contributions as a mentor to university students reflect the trust and recognition she has earned within both clinical and academic communities. These achievements collectively highlight her as a dedicated and influential figure in dietetics and clinical nutrition.

Research Skill🔬

Arezina Kasti possesses a robust and well-rounded set of research skills, honed through decades of clinical practice and academic pursuit. She demonstrates expertise in designing and conducting clinical trials, as evidenced by her PhD research on the Mediterranean-Low FODMAP diet’s impact on irritable bowel syndrome (IBS). Her methodological capabilities include randomized controlled trials, volatomics analysis, retrospective studies, and nutritional assessment tools. She is adept at translating clinical observations into structured research questions and producing evidence-based interventions with measurable outcomes. Arezina is also skilled in data collection, statistical analysis, scientific writing, and presenting findings at both national and international conferences. Her collaborations with multidisciplinary teams highlight her ability to integrate clinical nutrition with gastroenterology and public health. Furthermore, her involvement in the validation of diagnostic tools and her published literature in peer-reviewed journals reflect a deep understanding of research ethics, protocol development, and publication standards—making her a competent and impactful researcher in clinical nutrition.

Conclusion💡

Arezina Kasti is a highly suitable candidate for the Women Researcher Award, especially in categories that value clinical experience, translational research, public health impact, and education. Her work bridges the gap between dietary therapy and chronic gastrointestinal disease management. While more international leadership in research projects or policy could enhance her profile further, her consistent contributions and research trajectory make her an outstanding contender.

Publications Top Noted✍️

  • Kasti AN, Nikolaki MD, Synodinou KD, Katsas KN, Petsis K, Lambrinou S, et al.
    The effects of stevia consumption on gut bacteria: friend or foe?
    Year: 2022 | Citations: 42

  • Kasti AN, Synodinou KD, Pyrousis IA, Nikolaki MD, Triantafyllou KD.
    Probiotics regulating inflammation via NLRP3 inflammasome modulation: a potential therapeutic approach for COVID-19
    Year: 2021 | Citations: 24

  • Kasti A, Petsis K, Lambrinou S, Katsas K, Nikolaki M, Papanikolaou IS, et al.
    A combination of Mediterranean and low-FODMAP diets for managing IBS symptoms? Ask your gut!
    Year: 2022 | Citations: 21

  • Synodinou KD, Nikolaki MD, Triantafyllou K, Kasti AN.
    Immunomodulatory effects of probiotics on COVID-19 infection by targeting the gut–lung axis microbial cross-talk
    Year: 2022 | Citations: 19

  • Kasti AN, Theodorakopoulou M, Katsas K, Synodinou KD, Nikolaki MD, et al.
    Factors Associated with interruptions of Enteral Nutrition and the impact on macro-and Micronutrient deficits in ICU patients
    Year: 2023 | Citations: 12

  • Kasti AN, Katsas K, Petsis K, Lambrinou S, Synodinou KD, Kapetani A, et al.
    Is the Mediterranean Low Fodmap Diet Effective in Managing Irritable Bowel Syndrome Symptoms and Gut Microbiota? An Innovative Research Protocol
    Year: 2024 | Citations: 7

  • Nikolaki MD, Kasti AN, Katsas K, Petsis K, Lambrinou S, Patsalidou V, et al.
    The Low-FODMAP Diet, IBS, and BCFAs: Exploring the Positive, Negative, and Less Desirable Aspects—A Literature Review
    Year: 2023 | Citations: 7

  • O’Brien L, Kasti A, Halmos EP, Tuck C, Varney J.
    Evolution, adaptation, and new applications of the FODMAP diet
    Year: 2024 | Citations: 6

  • Kipouros M, Vamvakari K, Kalafati IP, Evangelou I, Kasti AN, Kosti RI, et al.
    The level of adherence to the ESPEN guidelines for energy and protein intake prospectively influences weight loss and nutritional status in patients with cancer
    Year: 2023 | Citations: 6

  • Zavras N, Vaou N, Zouganeli S, Kasti A, Dimitrios P, Vaos G.
    The Impact of Obesity on Perioperative Outcomes for Children Undergoing Appendectomy for Acute Appendicitis: A Systematic Review
    Year: 2023 | Citations: 5

  • Evangelou I, Vamvakari K, Kalafati IP, Kipouros M, Kasti AN, Kosti RI, et al.
    Depression and Anxiety Mediate the Associations between Nutritional Status, Functional Capacity, and Quality of Life in Patients with Cancer
    Year: 2023 | Citations: 3

  • Vamvakari K, Evangelou I, Kalafati IP, Kipouros M, Kosti RI, Kasti AN, et al.
    Assessment of nutritional status using objective and subjective methods in Greek patients with cancer
    Year: 2023 | Citations: 3

Yijun Zheng | Oncology | Best Researcher Award

Published on by Global Scholar Awards

Mr. Yijun Zheng | Oncology| Best Researcher Award

Doctor at The Second Hospital & Clinical Medical School, Lanzhou University, China

Dr. Zheng Yijun, a PhD candidate in Surgery at Lanzhou University, has made notable contributions to the field of oncology through his research on the prevention and treatment of gastric cancer using traditional Chinese medicine. He has published three SCI papers, including one highly cited work, and serves as a reviewer for multiple esteemed journals. His research has been supported by the National Natural Science Foundation of China, and he has participated in several significant provincial projects. In addition to his research, Dr. Zheng authored a book on infectious disease prevention, further contributing to public health education. While his research demonstrates strong academic engagement and innovative interdisciplinary approaches, his profile could be further enhanced by increasing international collaborations, taking on editorial or leadership roles, and gaining more industry-related experience. Overall, Dr. Zheng’s impactful work in traditional medicine and oncology positions him as a strong candidate for the Best Researcher Award.

Professional Profile 

Education🎓

Dr. Zheng Yijun is currently pursuing a Ph.D. in Surgery at Lanzhou University, where he is engaged in research focusing on the prevention and treatment of gastric cancer, particularly through the lens of traditional Chinese medicine. His academic journey includes significant involvement in research projects, and he has already contributed to the publication of multiple papers, including two SCI-indexed articles, one of which has achieved high citation rates. In addition to his ongoing doctoral work, Dr. Zheng holds a strong foundation in medical sciences, having participated in a variety of academic initiatives, including projects funded by the National Natural Science Foundation of China. His academic achievements reflect a dedication to advancing medical research, especially in the intersection of modern surgery and traditional medicine. Dr. Zheng’s contributions are a testament to his commitment to both academic excellence and the development of practical, impactful research in the medical field.

Professional Experience📝

Dr. Zheng Yijun has gained valuable professional experience through his research and academic contributions during his time at Lanzhou University. As a PhD candidate in Surgery, he has been involved in multiple research projects, including two funded by the National Natural Science Foundation of China. His research primarily focuses on the integration of traditional Chinese medicine with modern oncology, specifically in the prevention and treatment of gastric cancer. Dr. Zheng has also contributed to the academic community by publishing several papers in SCI-indexed journals, with one achieving significant citation success. Additionally, he serves as a reviewer for respected journals such as Frontiers in Medicine and the International Journal of Clinical Practice, highlighting his role in peer evaluation and academic engagement. While his professional experience is primarily academic, Dr. Zheng’s involvement in funded research and editorial duties reflects his growing influence and expertise in the medical research community.

Research Interest🔎

Dr. Zheng Yijun’s primary research interest lies in the prevention and treatment of gastric cancer through the application of traditional Chinese medicine (TCM). He is focused on exploring the pharmacological properties of various herbal compounds and their potential to complement or enhance conventional cancer therapies. His research aims to establish a scientific foundation for integrating TCM into modern oncological practices, offering alternative or adjunct therapies for cancer patients. Dr. Zheng’s work involves a multidisciplinary approach, combining molecular biology, pharmacology, and clinical medicine to uncover key mechanisms of action behind TCM’s therapeutic effects. Additionally, he has contributed to research on the molecular mechanisms of lymph node metastasis in gastric cancer, aiming to identify critical biomarkers and therapeutic targets. His work is not only advancing knowledge in oncology but also promoting the clinical application of traditional treatments, ultimately striving to improve patient outcomes through a holistic approach to cancer care.

Award and Honor🏆

Dr. Zheng Yijun has earned notable recognition for his academic and research achievements, particularly in the field of gastric cancer treatment through traditional Chinese medicine. One of his most significant accomplishments is the high citation rate of his SCI-published paper, which placed it in the top 1% for citations, underscoring the impact of his research in the scientific community. Additionally, Dr. Zheng has been awarded research funding for his projects, including support from the National Natural Science Foundation of China, highlighting his contributions to advancing medical knowledge. His work is also recognized through his active role as a reviewer for respected journals, such as Frontiers in Medicine and the International Journal of Clinical Practice, further establishing his reputation within the medical research field. Although he has not yet received specific formal awards or honors, his growing body of impactful work and involvement in key research initiatives place him in a strong position for future accolades.

Research Skill🔬

Dr. Zheng Yijun possesses a diverse set of research skills that enable him to conduct impactful studies in the field of oncology, particularly in integrating traditional Chinese medicine with modern cancer therapies. His expertise lies in molecular biology, pharmacology, and clinical research, allowing him to explore the therapeutic potential of herbal compounds in the treatment of gastric cancer. Dr. Zheng is skilled in experimental design, data analysis, and the use of various research methodologies to investigate complex biological processes, such as lymph node metastasis in gastric cancer. His ability to collaborate on multidisciplinary projects has been key to his success, particularly in securing funding from the National Natural Science Foundation of China. Furthermore, his experience as a reviewer for prominent medical journals reflects his strong analytical skills and deep understanding of the current scientific landscape. Dr. Zheng’s technical proficiency, combined with his critical thinking and problem-solving abilities, makes him a capable and effective researcher in his field.

Conclusion💡

Dr. Zheng Yijun demonstrates commendable strengths in scientific research, particularly in the integration of traditional Chinese medicine with oncology. His citation impact, involvement in funded projects, and academic reviewing roles support a strong candidacy for the Best Researcher Award. While expanding international collaborations, assuming leadership/editorial roles, and gaining industry exposure would strengthen his profile further, he is a suitable and promising candidate for this award.

Publications Top Noted✍️

  • Title: Corrigendum to: CCDC25 may be a potential diagnostic and prognostic marker of hepatocellular carcinoma: Results from microarray analysis

  • Authors: H. Deng, J. Zhang, Y. Zheng, X. Xu, Y. Zhang

  • Journal: Frontiers in Surgery

  • Year: 2023

  • DOI: 10.3389/fsurg.2022.878648

  • Article Type: Corrigendum

Ze-Min Yang | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by Global Scholar Awards

Prof. Ze-Min Yang | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

College teachers at Guangdong Pharmaceutical University, China

Professor Ze-Min Yang is a distinguished researcher specializing in metabolic disease pathogenesis and pharmacological research integrating Traditional Chinese Medicine (TCM) with Western medicine. With over 40 academic publications, including 13 SCI-indexed papers, and three invention patents, he has made significant contributions to biomedical research. He has led multiple prestigious projects, including National Natural Science Foundation grants and provincial research collaborations, demonstrating strong leadership and innovation. Serving as Deputy Director at Guangdong Pharmaceutical University, he plays a key role in academic mentorship and scientific evaluation at the provincial level. His accolades, such as “Outstanding Science and Technology Worker” and “Outstanding Teacher,” further highlight his excellence. While his research output is impressive, enhancing international collaborations, increasing citation impact, and expanding interdisciplinary applications could further strengthen his global recognition. Overall, his achievements and leadership make him a strong candidate for the Best Researcher Award, recognizing his impactful contributions to science and medicine.

Professional Profile 

Education

Professor Ze-Min Yang has a strong academic foundation spanning multiple disciplines. He earned his Ph.D. in 2012 from the Institute of Spleen and Stomach Research at Guangzhou University of Traditional Chinese Medicine, specializing in integrated traditional Chinese and Western medicine clinical practice. Prior to this, he obtained a Master’s degree in Hydrobiology from the Hydrobiology Research Center of Jinan University in 2005, demonstrating his expertise in biological sciences. His academic journey began with a Bachelor’s degree in Freshwater Fisheries from the Department of Fisheries at Southwest Agricultural University in 2002. This diverse educational background has provided him with a unique interdisciplinary perspective, integrating biomedical sciences, traditional medicine, and hydrobiology. His advanced training and research experience have contributed to his expertise in metabolic disease pathogenesis and pharmacological research, reinforcing his position as a leading academic in the field of biomedical and pharmaceutical sciences.

Professional Experience

Professor Ze-Min Yang has an extensive professional background in biomedical and pharmaceutical sciences. He currently serves as a faculty member in the Department of Biochemistry and Molecular Biology at the School of Basic Medical Sciences, Guangdong Pharmaceutical University. Additionally, he holds the position of Deputy Director of the Experimental Teaching Center, where he plays a key role in advancing scientific research and education. His expertise is recognized at the provincial level, as he actively contributes as an expert in science and technology project evaluation and acceptance for both Guangdong Province and Guangzhou City. Throughout his career, he has led multiple prestigious research projects, including those funded by the National Natural Science Foundation and Guangdong Provincial Science and Technology Department. His leadership in academic research, combined with his contributions to scientific evaluation and mentorship, underscores his dedication to advancing biomedical sciences and fostering innovation in traditional Chinese and Western medicine integration.

Research Interest

Professor Ze-Min Yang’s research interests focus on the pathogenesis of metabolic diseases and the pharmacological effects of integrating Traditional Chinese Medicine (TCM) with Western medicine. His work explores innovative approaches to understanding and treating metabolic disorders through a combination of molecular biology, biochemistry, and traditional herbal medicine. He is particularly interested in identifying bioactive compounds in TCM that can be used for drug development and disease management. His interdisciplinary research extends to studying the mechanisms of metabolic regulation, inflammation, and gut microbiota interactions in disease progression. By bridging modern biomedical research with traditional healing practices, he aims to develop novel therapeutic strategies that are both scientifically validated and culturally relevant. His contributions, supported by multiple national and provincial research grants, significantly advance the integration of TCM with evidence-based medicine, enhancing its global recognition and application in modern healthcare.

Award and Honor

Professor Ze-Min Yang has received numerous awards and honors in recognition of his outstanding contributions to scientific research, education, and innovation. He has been honored with titles such as “Outstanding Science and Technology Worker,” “Advanced Teaching Worker,” and “Outstanding Teacher” by Guangdong Pharmaceutical University, reflecting his excellence in both research and academia. His leadership in biomedical sciences and commitment to integrating Traditional Chinese Medicine with Western medicine have earned him prestigious recognition at institutional and provincial levels. Additionally, his contributions as an expert in science and technology project evaluation for Guangdong Province and Guangzhou City highlight his influence in shaping research policies and advancements. With multiple funded projects, over 40 academic publications, and three invention patents, his work has significantly impacted the field of metabolic disease research. These accolades reinforce his reputation as a distinguished scientist and educator, making him a strong candidate for prestigious research awards.

Research Skill

Professor Ze-Min Yang possesses a diverse and advanced set of research skills, particularly in the fields of biochemistry, molecular biology, and pharmacology. His expertise lies in investigating the pathogenesis of metabolic diseases and the therapeutic potential of Traditional Chinese Medicine (TCM) integrated with Western medicine. He has extensive experience in experimental design, data analysis, and clinical applications, allowing him to bridge theoretical research with practical medical solutions. His work involves drug discovery, biomarker identification, and molecular mechanism studies, utilizing cutting-edge laboratory techniques such as cell culture, gene expression analysis, and bioinformatics. Additionally, his ability to lead multi-disciplinary research projects, secure national and provincial funding, and collaborate with experts in biomedical sciences demonstrates his strong project management and leadership skills. His contributions, including over 40 academic publications and three patents, highlight his ability to drive innovative research that advances both scientific knowledge and clinical applications.

Conclusion

Professor Ze-Min Yang is a strong candidate for the Best Researcher Award due to his extensive research in metabolic diseases, leadership in TCM and Western medicine integration, multiple prestigious grants, and significant academic contributions. To further enhance his profile, international collaborations, higher-impact publications, and broader interdisciplinary work would strengthen his candidacy.

Publications Top Noted

  • Title: “Identification of microRNA and analysis of target genes in Panax ginseng”

    Authors: Yingfang Wang, Yanlin Chen, Mengyuan Peng, Yongqin Yin, Yu Zeng

    Year: 2023

    Citations: 8

    Source: Chinese Herbal Medicines

  • Title: “Astragalus Polysaccharides Alleviate Type 2 Diabetic Rats by Reversing the Expressions of Sweet Taste Receptors and Genes Related to Glycolipid Metabolism in Liver”

    Authors: Mengjuan Luo, Ying Wang, Siyu Chen, Zemin Yang

    Year: 2022

    Citations: 14

    Source: Frontiers in Pharmacology